全球数位病理学的成长机会

远端病理学中的人工智慧增加了远距离诊断和协作模型的潜力

随着人们对精准医疗的兴趣日益浓厚，以及医院和实验室对远端医疗和数数位解决方案的需求不断增长，数位病理学有机会在临床、製药和研究应用中发展。

基于人工智慧的演算法以及资料管理和分析软体的进步为改进工作流程、自动化繁琐的任务以及更好地利用所有领域的工作空间提供了巨大的潜力。

该报告研究了数位病理学市场并提供了 2022 年至 2027 年的预测。我们将数位病理学定义为为管理和解释整个组织病理学幻灯片提供数位环境的系统、应用程式和服务。该分析提供了有关市场集中度和演变、主要数位病理解决方案提供者、应用领域和认证的资讯。这项研究帮助供应商了解世界各地区在不同应用领域发生的重要趋势。

数位病理市场顶部整合，底部高度分散。在整个价值链中，大公司的地位突出，并透过併购发展起来。

该研究对北美、欧洲和亚太地区的数位病理学细分市场（硬体、软体和服务）进行了深入分析，重点关注预测期内的新兴商业模式和成长机会。

目录

战略衝动

• 为什么成长如此困难？
• The Strategic Imperative 8（TM）
• 关键策略激励措施对数位病理产业的影响
• 成长机会推动Growth Pipeline Engine（TM）

成长机会分析

• 分析范围
• 按产品细分
• 按地区细分
• 主要竞争
• 成长指标
• 数位病理工作流程
• 数位病理解决方案销售管道
• 生长促进因子
• 成长抑制因素
• 预测假设
• 收益预测
• 收益预测（按产品）
• 按产品分類的收益比率预测
• 按地区分類的收益预测
• 按地区分類的收益比率预测
• 收益预测分析
• 行业现状 - 地理亮点
• 价格趋势和预测分析
• 竞争环境
• 收益占有率
• 收益占有率分析
• 按供应商类型分類的数位病理学生态系统
• 特色企业
• 企业解决方案
• 着名的伙伴关係和合作
• 合作伙伴类型和机会
• 商业模式概述
• 按业务模式分類的解决方案采用曲线
• 数位病理学中的人工智慧
• 采用基于人工智慧的数位病理技术
• 数位病理学中的人工智慧 - 当前和未来的应用
• 创业投资/私募股权资金筹措

成长机会分析：硬体

• 成长指标
• 收益预测
• 按地区分類的收益预测
• 预测分析

成长机会分析：软体

• 成长指标
• 收益预测
• 按地区分類的收益预测
• 预测分析

成长机会分析：服务

• 成长指标
• 收益预测
• 按地区分類的收益预测
• 预测分析

成长机会分析：北美

• 市场动态-北美数位病理市场
• 成长指标
• 收益预测
• 收益预测（按产品）
• 预测分析

成长机会分析：欧洲

• 市场动态- 欧洲数位病理市场
• 成长指标
• 收益预测
• 收益预测（按产品）
• 预测分析

成长机会分析：亚太地区

• 市场动态-亚太数位病理市场
• 成长指标
• 收益预测
• 收益预测（按产品）
• 预测分析

法规情势分析

• 法规现况 -美国数位病理市场
• FDA WSI 器材评估的上市前申请要求
• 端到端解决方案的法规里程碑
• FDA核准/510(k) 透明产品
• 美国新的数位病理学附加代码
• 法规现况 - 欧洲数位病理市场
• CE标誌产品

成长机会宇宙

• 成长机会1：亚太地区新兴市场的扩张
• 成长机会2：协力网路与资料共用平台
• 成长机会 3：影像微阵列 (IMA)整合
• 成长机会 4：整合诊断与企业影像工作流程

下一步

AI in Telepathology Enhancing Potential for Remote Diagnosis and Collaborative Models

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications.

Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, automating tedious tasks, and making better use of workspaces in all areas of the industry.

The report examines the digital pathology market and provides a forecast from 2022 to 2027. Frost & Sullivan defines digital pathology as systems, applications, and services that offer a digital environment for managing and interpreting whole slides for histopathology. The analysis provides information on market concentration and evolution, the leading digital pathology solutions providers, application areas, and certifications. This study will help vendors understand critical trends emerging for various application domains in each region globally.

The digital pathology market is consolidated at the top and highly fragmented at the bottom, with many small players offering focused solutions. Large companies have a prominent presence across the value chain, which they have developed through mergers and acquisitions.

The global study provides a detailed analysis of digital pathology market segments (hardware, software, and services) in North America, Europe, and Asia-Pacific, highlighting emerging business models and growth opportunities over the forecast period.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Digital Pathology Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of Analysis
• Segmentation by Product
• Segmentation by Region
• Key Competitors
• Growth Metrics
• Digital Pathology Workflow
• Distribution Channels for Digital Pathology Solutions
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast by Product
• Percent Revenue Forecast by Product
• Revenue Forecast by Region
• Percent Revenue Forecast by Region
• Revenue Forecast Analysis
• State of the Industry-Geographical Highlights
• Pricing Trends and Forecast Analysis
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Digital Pathology Ecosystem by Vendor Type
• Companies to Watch
• Company Solutions
• Notable Partnerships and Collaborations
• Types of Partnership and Opportunities
• Business Models Overview
• Solution Adoption Curve by Business Model
• AI in Digital Pathology
• AI-based Digital Pathology Technology Adoption
• AI in Digital Pathology-Current and Future Applications
• Venture Capital/Private Equity Funding

Growth Opportunity Analysis: Hardware

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Software

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Services

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: North America

• Market Dynamics-NA Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Growth Opportunity Analysis: Europe

• Market Dynamics-Europe Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Growth Opportunity Analysis: Asia-Pacific

• Market Dynamics-APAC Digital Pathology Market
• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Product
• Forecast Analysis

Regulatory Landscape Analysis

• Regulatory Landscape-US Digital Pathology Market
• Pre-market Application Requirements for FDA Evaluation of a WSI Device
• Regulatory Landmarks for End-to-end Solutions
• FDA-Approved/510(k)-cleared Products
• New Digital Pathology Add-on Codes in the United States
• Regulatory Landscape-Europe Digital Pathology Market
• CE-marked Products

Growth Opportunity Universe

• Growth Opportunity 1: Expansion in APAC Emerging Markets
• Growth Opportunity 2: Collaborative Networks and Data Sharing Platforms
• Growth Opportunity 3: Integration of Image Microarrays (IMAs)
• Growth Opportunity 4: Integrated Diagnosis and Enterprise Imaging Workflows

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer